Breaking News

Ashland Opens Expanded Technical Center in Shanghai

October 26, 2016

Doubles size of the original complex to support solid dosage forms

Ashland has opened its Pharmaceutical Technical Center in Shanghai following a major expansion, doubling the size of the original complex built in 2008. The complex now accommodates all of the scientists and equipment to provide services for complex challenges for solid dosage forms.
 
Ashland is now able to provide a range of pharmaceutical technical services that include binding enhancement, disintegration improvement, modified release, solubilizing and film coating to help companies in China improve the performance of tablets and other solid dosage forms.
 
Ashland’s chairman and chief executive officer, William A. Wulfsohn, said, “The grand opening of Ashland’s pharmaceutical technical center is a testament to the demand for our scientists and process engineers who can look at a problem from a molecular perspective and move it all the way to a formulation and manufacturing solution. It is our sincere hope and expectation that this newly expanded facility will be the site of many comprehensive solutions that further advance the pharmaceutical projects of our customers in China.”
 
Ashland also operates pharmaceutical technical centers in Wilmington, DE, and Hyderabad, India.

Related Contract Manufacturing:

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO